Growing community of inventors

Riverdale, NY, United States of America

Marta Filizola

Average Co-Inventor Count = 4.72

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 6

Marta FilizolaBarry S Coller (4 patents)Marta FilizolaWenwei Huang (3 patents)Marta FilizolaCraig J Thomas (3 patents)Marta FilizolaMin Shen (3 patents)Marta FilizolaJoshua McCoy (3 patents)Marta FilizolaJonathan A Javitch (1 patent)Marta FilizolaThomas Edward Prisinzano (1 patent)Marta FilizolaJian-kang Jiang (1 patent)Marta FilizolaMichael Andrew Foley (1 patent)Marta FilizolaMarie-Laure Rives (1 patent)Marta FilizolaMarta Filizola (5 patents)Barry S CollerBarry S Coller (24 patents)Wenwei HuangWenwei Huang (25 patents)Craig J ThomasCraig J Thomas (24 patents)Min ShenMin Shen (15 patents)Joshua McCoyJoshua McCoy (3 patents)Jonathan A JavitchJonathan A Javitch (11 patents)Thomas Edward PrisinzanoThomas Edward Prisinzano (10 patents)Jian-kang JiangJian-kang Jiang (10 patents)Michael Andrew FoleyMichael Andrew Foley (8 patents)Marie-Laure RivesMarie-Laure Rives (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. The Rockefeller University (4 from 712 patents)

2. Icahn School of Medicine at Mount Sinai (4 from 269 patents)

3. The United States of America, As Represented by the Secretary, Department of Health and Human Services (3 from 3,439 patents)

4. Columbia University (1 from 2,488 patents)


5 patents:

1. 11192889 - Tetrahydronaphthyridinepentanamide integrin antagonists

2. 9868730 - Kappa opioid receptor selective compounds, compositions, and uses thereof

3. 9532989 - Oxadiazolo[3,2-A]pyrimidines and thiadiazolo[3,2-A]pyrimidines

4. 9303044 - 7-(piperazin-1-yl)-5H-[1,3,4]thiadiazolo[3,2-A]pyrimidin-5-ones for the treatment of thrombotic disorders

5. 9066948 - Oxadiazolo[3,2-a]pyrimidines and thiadiazolo[3,2-a]pyrimidines

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/13/2025
Loading…